Literature DB >> 18651822

Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.

Ajay E Kuriyan, Richard P Phipps, Charles W O'Loughlin, Steven E Feldon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18651822      PMCID： PMC2752272          DOI： 10.1089/thy.2007.0325

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  12 in total

Review 1.  Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.

Authors:  Bellur S Prabhakar; Rebecca S Bahn; Terry J Smith
Journal:  Endocr Rev       Date:  2003-12       Impact factor: 19.871

2.  15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway.

Authors:  Sarah G Harris; Roger S Smith; Richard P Phipps
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 3.  The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy.

Authors:  T J Smith
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

4.  Overexpression of immediate early genes in active Graves' ophthalmopathy.

Authors:  Mikael Lantz; Tereza Vondrichova; Hemang Parikh; Christofer Frenander; Martin Ridderstråle; Peter Asman; Magnus Aberg; Leif Groop; Bengt Hallengren
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

Review 5.  Pathogenesis of Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

6.  Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.

Authors:  Stephen E Feldon; D J John Park; Charles W O'Loughlin; Vu T Nguyen; Shira Landskroner-Eiger; Donald Chang; Thomas H Thatcher; Richard P Phipps
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

7.  Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.

Authors:  Raymond S Douglas; Andrew G Gianoukakis; Shweta Kamat; Terry J Smith
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients.

Authors:  Cacia V Soares-Welch; Vahab Fatourechi; George B Bartley; Charles W Beatty; Colum A Gorman; Rebecca S Bahn; Erik J Bergstralh; Cathy D Schleck; James A Garrity
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

9.  Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression.

Authors:  H James Cao; Rui Han; Terry J Smith
Journal:  Am J Physiol Cell Physiol       Date:  2003-01-08       Impact factor: 4.249

10.  Human lupus T cells resist inactivation and escape death by upregulating COX-2.

Authors:  Luting Xu; Li Zhang; Yajun Yi; Hee-Kap Kang; Syamal K Datta
Journal:  Nat Med       Date:  2004-02-29       Impact factor: 53.440
View more
  4 in total

Review 1.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

2.  Salinomycin and other polyether ionophores are a new class of antiscarring agent.

Authors:  Collynn F Woeller; Charles W O'Loughlin; Elisa Roztocil; Steven E Feldon; Richard P Phipps
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

Review 3.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

4.  Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.

Authors:  Ajay E Kuriyan; Collynn F Woeller; Charles W O'Loughlin; Richard P Phipps; Steven E Feldon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-08       Impact factor: 4.799
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.